Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People

Author:

Pang Yuanjie1ORCID,Kartsonaki Christiana12,Turnbull Iain1,Guo Yu3,Clarke Robert1,Chen Yiping12,Bragg Fiona1,Yang Ling12,Bian Zheng3,Millwood Iona Y.12,Hao Juanzhi4,Han Xianyong5,Zang Yajing6,Chen Junshi7,Li Liming38,Holmes Michael V.129,Chen Zhengming12

Affiliation:

1. Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population HealthUniversity of Oxford Oxford UK

2. Medical Research Council Population Health Research Unit, Nuffield Department of Population HealthUniversity of Oxford Oxford UK

3. Chinese Academy of Medical Sciences Beijing China

4. Qingdao Cancer Hospital QingdaoChina

5. Yongqinglu Community Health Service Center Qingdao China

6. Qingdao Center for Disease Prevention and Control Qingdao China

7. National Center for Food Safety Risk Assessment Beijing China

8. School of Public HealthPeking University

9. National Institute for Health Research Oxford Biomedical Research CentreOxford University Hospital Oxford UK

Funder

Kadoorie Charitable Foundation, Hong Kong

UK Wellcome Trust

Chinese Ministry of Science and Technology

Chinese National Natural Science Foundation

Publisher

Wiley

Subject

Hepatology

Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3